FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/21/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   8/21/2017     P    3000   A $0.0288   22533889   D    
Common Stock   8/21/2017     P    5000   A $0.025   22538889   D    
Common Stock   8/21/2017     P    5000   A $0.025   22543889   D    
Common Stock   8/21/2017     P    5000   A $0.0265   22548889   D    
Common Stock   8/21/2017     P    3000   A $0.0268   22551889   D    
Common Stock   8/21/2017     P    3000   A $0.0279   22554889   D    
Common Stock   8/21/2017     P    5000   A $0.0275   22559889   D    
Common Stock   8/21/2017     P    3000   A $0.0273   22562889   D    
Common Stock   8/21/2017     P    5000   A $0.0271   22567889   D    
Common Stock   8/21/2017     P    5000   A $0.0271   22572889   D    
Common Stock   8/21/2017     P    3000   A $0.0262   22575889   D    
Common Stock   8/22/2017     P    3000   A $0.0254   22578889   D    
Common Stock   8/22/2017     P    3000   A $0.0255   22581889   D    
Common Stock   8/22/2017     P    3000   A $0.0254   22584889   D    
Common Stock   8/22/2017     P    3000   A $0.0256   22587889   D    
Common Stock   8/22/2017     P    3000   A $0.0256   22590889   D    
Common Stock   8/22/2017     P    3000   A $0.0256   22593889   D    
Common Stock   8/22/2017     P    3000   A $0.0256   22596889   D    
Common Stock   8/22/2017     P    5000   A $0.0255   22601889   D    
Common Stock   8/23/2017     P    3000   A $0.0255   22604889   D    
Common Stock   8/23/2017     P    3000   A $0.0248   22607889   D    
Common Stock   8/23/2017     P    5000   A $0.0248   22612889   D    
Common Stock   8/23/2017     P    3000   A $0.0247   22615889   D    
Common Stock   8/23/2017     P    5000   A $0.0245   22620889   D    
Common Stock   8/23/2017     P    2000   A $0.0244   22622889   D    
Common Stock   8/23/2017     P    10000   A $0.0246   22632889   D    
Common Stock   8/23/2017     P    3000   A $0.0244   22635889   D    
Common Stock   8/23/2017     P    3000   A $0.0245   22638898   D    
Common Stock   8/23/2017     P    3000   A $0.023   22641889   D    
Common Stock   8/23/2017     P    3000   A $0.023   22644889   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 8/25/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.